study | n | Stage | Technique | total | RT dose (Gy) pelvic | inguinal | Split | CT | OS (%) | LC (%) | CFS (%) | toxicity overall | skin | diarrhea | BM | adherence (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vuong (ASCO 2008) | 26 | IMRT | 54-59.4 | 30 | 30 | cont | MMC, 5-FU | 71 (1 y) | 23 | 4 | 42 | 76 | ||||
McGill | 40 | 3d-CRT | 54-59.4 | 30 | 30 | cont | MMC, 5-FU | 85 (1 y) | 19 | 3 | 18 | 93 | ||||
Salama (2007) | 532 | T1-4N0-3 | IMRT | 51,5 | 45 | 45 | cont | MMC, 5-FU | 93 (18 mo) | 84 (18 mo) | 84 (18 mo) | 38 | 15 | 581 | ||
Chicago | ||||||||||||||||
Milano (2005) | 17 | T2-4N0-3 | IMRT | 54-59.4 | 45 | 45 | cont | MMC, 5-FU | 91 (2 y) | 82 (2 y) | 0 | 0 | 53 | 100 | ||
Chicago |